BridgeBio Pharma Quick Ratio 2018-2025 | BBIO
Historical quick ratio values for BridgeBio Pharma (BBIO) over the last 10 years.
| BridgeBio Pharma Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2025-03-31 |
$0.69B |
$0.15B |
4.54 |
| 2024-12-31 |
$0.00B |
$0.15B |
0.00 |
| 2024-09-30 |
$0.00B |
$0.14B |
0.00 |
| 2024-06-30 |
$0.00B |
$0.13B |
0.00 |
| 2024-03-31 |
$0.00B |
$0.14B |
0.00 |
| 2023-12-31 |
$0.00B |
$0.14B |
0.00 |
| 2023-09-30 |
$0.00B |
$0.11B |
0.00 |
| 2023-06-30 |
$0.00B |
$0.11B |
0.00 |
| 2023-03-31 |
$0.00B |
$0.10B |
0.00 |
| 2022-12-31 |
$0.00B |
$0.12B |
0.00 |
| 2022-09-30 |
$0.00B |
$0.12B |
0.00 |
| 2022-06-30 |
$0.00B |
$0.14B |
0.00 |
| 2022-03-31 |
$0.00B |
$0.10B |
0.00 |
| 2021-12-31 |
$0.00B |
$0.14B |
0.00 |
| 2021-09-30 |
$0.00B |
$0.10B |
0.00 |
| 2021-06-30 |
$0.00B |
$0.13B |
0.00 |
| 2021-03-31 |
$0.00B |
$0.10B |
0.00 |
| 2020-12-31 |
$0.00B |
$0.10B |
0.00 |
| 2020-09-30 |
$0.00B |
$0.08B |
0.00 |
| 2020-06-30 |
$0.00B |
$0.09B |
0.00 |
| 2020-03-31 |
$0.00B |
$0.07B |
0.00 |
| 2019-12-31 |
$0.00B |
$0.06B |
0.00 |
| 2019-09-30 |
$0.00B |
$0.04B |
0.00 |
| 2019-06-30 |
$0.00B |
|
0.00 |
| 2019-03-31 |
$0.00B |
|
0.00 |
| 2018-12-31 |
$0.00B |
|
0.00 |
| 2018-09-30 |
$0.00B |
|
0.00 |
| 2017-12-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-GENERIC DRG |
$7.324B |
$0.222B |
|
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
|
